{"id":"W2745836136","doi":"10.1016/j.jad.2017.08.040","title":"The safety and tolerability of cariprazine in patients with manic or mixed episodes associated with bipolar I disorder: A 16-week open-label study","year":2017,"lang":"en","type":"article","venue":"Journal of Affective Disorders","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Janssen Pharmaceuticals; Seattle Genetics; Genentech; Agency for Healthcare Research and Quality; Otsuka Pharmaceutical; Lundbeckfonden; GlaxoSmithKline; Gedeon Richter; European Association for Behavioural and Cognitive Therapies; Sunovion; Acadia University; Pharmaceuticals Bayer; Allergan; AstraZeneca; Depomed; Abbott Fund; American Psychiatric Publishing; Teva Pharmaceutical Industries; Stanford University; Pfizer; Cephalon; AstraZeneca Korea; Merck; Abbott Laboratories","keywords":"Tolerability; Young Mania Rating Scale; Akathisia; Discontinuation; Mania; Bipolar I disorder; Extrapyramidal symptoms; Medicine; Bipolar disorder; Internal medicine; Somnolence; Adverse effect; Psychology; Anesthesia; Psychiatry; Mood; Antipsychotic","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002195703,0.0007027917,0.001302652,0.0002799143,0.0003690197,0.0004747735,0.0004403827,0.0006853673,0.001796177],"category_scores_gemma":[0.001831181,0.0003695258,0.0008567277,0.0003135585,0.0006267728,0.0007240701,0.0002833013,0.001308935,0.0003361922],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004592146,"about_ca_system_score_gemma":0.0004875712,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000462256,"about_ca_topic_score_gemma":0.0008265238,"domain_scores_codex":[0.9993863,0.0003110976,0.0000624304,0.00008929353,0.00008097027,0.00006984401],"domain_scores_gemma":[0.9984018,0.0003672906,0.0006030525,0.0001751489,0.0001045999,0.0003480592],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6736857,0.06198176,0.08515569,0.001198648,0.002163176,0.0006382839,0.0008051892,0.001344327,0.04834073,0.00007634542,0.0009985541,0.1236116],"study_design_scores_gemma":[0.1713051,0.6498777,0.1695202,0.00006350841,0.0008701338,0.0008978408,0.0001760825,0.001698505,0.003553543,0.00007554004,0.001904974,0.00005690534],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9986541,0.0007157059,0.0001469677,0.00003950681,0.00001191562,0.0001906187,0.00008397263,0.00001107393,0.0001461272],"genre_scores_gemma":[0.9981422,0.0003927347,0.0004975119,0.0001385206,0.00008076705,0.0002485772,0.000235655,0.000004611081,0.0002592359],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002195703,"threshold_uncertainty_score":0.01161212,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01511417322898673,"score_gpt":0.282771336192963,"score_spread":0.2676571629639763,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}